416 SQ3370–001 is a Multi-Center Open-Label Phase I Dose-Escalation Study to Test a Novel Intratumoral and Systemic Approach to Treat Advanced Solid Tumors
JOURNAL FOR IMMUNOTHERAPY OF CANCER（2020）
Key words
Tumor Targeting
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined